At Alpinia we combine centuries old knowledge about traditional medicinal plants with scientific investigations. Cutting-edge technologies and modern scientific resources are used to develop products, that are the result of research by a dedicated team of experts who work to ensure quality, safety and efficacy of our health care and cosmetic products.
The Universitätsklinikum Hamburg Eppendorf (UKE) performed a phase IIa trial (SABA study, in patients with relapsing-remitting multiple sclerosis). Our Frankincense extract was applied as study medication. The patients were treated for eight months with an option to extend treatment for up to 36 months. Eighty patients were screened at two centers, 38 patients were included in the trial, 28 completed the 8-month treatment period and 18 of these participated in the extension period. The investigators considered this Frankincense extract to be safe in the applied doses, and exposure to it was beneficial for patients with relapsing-remitting multiple sclerosis.
(Stürner KH, et al. J Neurol Neurosurg Psychiatry 2018;89:330–338,